JSW Energy plans to raise ₹10,000 crore through qualified institutional placement and another ₹3,000 crore from the promoters ...
Against all the odds, Roche's Genentech unit has won FDA approval for its clot-busting drug TNKase as a treatment for acute ischaemic stroke, after all but abandoning the project a couple of years ago ...
Bank of America Leveraged Finance Conference December 2, 2025 7:30 AM ESTCompany ParticipantsDoug Garis - Executive VP ...
TNKase is the first stroke medicine approved by the FDA in nearly 30 years. The U.S. Food and Drug Administration (FDA) has approved Genentech’s TNKase (tenecteplase), a thrombolytic or ...
IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown that ...
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...
TAMPA, Fla. — Tampa Bay’s main airport has a new leader. Tampa International Airport’s new CEO, Michael Stephens, has been on the job for about five weeks now after being selected for the position ...
Targeted adjunctive intracoronary delivery of the low-dose recombinant tissue plasminogen activator alteplase does not improve microvascular obstruction or major adverse cardiovascular events (MACE) ...
Introduction: Alteplase is known to increase the risk of blood-brain barrier integrity disruption, potentiating hemorrhage and edema. Evolving edema reduces chances of good functional outcomes. There ...
NAD+ infusions are not FDA-approved and their benefits are not firmly established. Infusion sessions can be expensive and may cause side effects like dizziness or nausea. B vitamins may help increase ...
For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common and associated with more severe symptoms, worse quality of life and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results